MedPath

Clinical trial of Manjishtha Kwath in painful menstruatio

Phase 2
Conditions
Health Condition 1: N944- Primary dysmenorrhea
Registration Number
CTRI/2022/07/043732
Lead Sponsor
Dr Monika Annasaheb Kate
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)female patients of age group 13-19 years

2) Patients with Primary Dysmenorrhoea

3) Diagnosed patients of Udavartini Yoniyapad according to symptoms.

4) Unmarried Female Patients

Exclusion Criteria

1) Patients of Secondary dysmenorrhoea

2) Married Female Patients

3) Patients with K/H/O fibroid, endometriosis, adenomyosis 4) K/H/O congenital anamolies of pelvic reproductive organ

5) K/H/O Oligomenorrhoea, PCOS, puberty menorrhagia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To reduce the severity and incidence of pain during the menses <br/ ><br>2. To assess the pain with the help of VAS-SCALE <br/ ><br>3. To improve quality of life <br/ ><br>4. To reduce the incidence and severity of pain <br/ ><br>5. To study in detail the nidana, samprapti of udavartini yonivyapad and etiopathogenesis of primary dysmenorrhea <br/ ><br>6. To assess the improvement in the udavartini yonivyapad after treatment of 3 cyclesTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
<br/ ><br>1. To reduce the severity and incidence of pain during the menses . <br/ ><br>2. VAS-SCALE <br/ ><br>3. To improve quality of life. <br/ ><br>4. Incidance and severity of pain can be reduced. <br/ ><br>5. To study in detail the nidana, samprapti of Udavartini Yonivyapad and etiopathogenesis of primary dysmenorrhoea <br/ ><br>6. To assess the improvement in the Udavartini Yonivyapad after treatment <br/ ><br>7. To achieve improvement in Udavartini Yonivyapad in a span of 4 months <br/ ><br>Timepoint: 3months
© Copyright 2025. All Rights Reserved by MedPath